A comparative study by Alabanza et al. [22] demonstrated that CARs incorporating CD8α-derived hinge and transmembrane regions induced lower cytokine release and reduced activation-induced cell death (AICD) compared to CARs with CD28-derived segments, while maintaining comparable tumor clearance in vivo. Here, CD8A is linked to neoplasm.